Diabetes Mellitus, Type 2 study: Polygenic Risk Score
Official title Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
ClinicalTrials.gov ID: NCT06586203
What this study is testing
- What it's testing
- The study wants to see if knowing a person’s genetic risk for heart and kidney complications helps them reach better blood sugar, blood pressure, and kidney health targets over 18 months.
- Who it's for
- Adults with type 2 diabetes who have heart disease or kidney problems.
- What's involved
- Participants give a saliva sample for a genetic test, visit the clinic every 3 months for check‑ups and tests, and complete two quality‑of‑life questionnaires.
- Time commitment
- The study lasts 18 months, with clinic visits every 3 months and a few questionnaires to fill out.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients with T2D of both sexes regardless of ethnicity, level of diabetes control and presence of complications.
- Able to visit the study site 7 times
- Able and willing to provide informed consent to the clinical and PRS parts of the study.
You likely can't join if
- Any condition that may impact participation in a real-world study according to the treating physician.
- People with a high frailty index as no benefit of therapeutic intensification has been demonstrated in these diabetic patients.
- People who refuse to be informed of their cardiorenal risk score.
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.